Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP)
CUSIP: 21833P301
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 17,685,185
- Total 13F shares
- 10,752,925
- Share change
- +2,188,821
- Total reported value
- $486,116,698
- Put/Call ratio
- 138%
- Price per share
- $45.25
- Number of holders
- 107
- Value change
- +$101,256,908
- Number of buys
- 62
- Number of sells
- 38
Quarterly Holders Quick Answers
What is CUSIP 21833P301?
CUSIP 21833P301 identifies CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 21833P301:
Top shareholders of CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP |
13F
|
Company |
11%
|
2,025,000
|
$79,461,000 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
4%
|
701,597
|
$27,530,666 | — | 31 Mar 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
3.2%
|
559,271
|
$21,945,794 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.5%
|
437,264
|
$17,158,239 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.3%
|
415,000
|
$16,284,600 | — | 31 Mar 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
2.3%
|
405,000
|
$15,892,200 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.1%
|
369,167
|
$14,486,113 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.9%
|
339,074
|
$13,362,898 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.8%
|
324,902
|
$12,749,154 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.5%
|
259,456
|
$10,181,053 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.2%
|
220,862
|
$8,666,624 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
192,495
|
$7,554,000 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
1%
|
185,148
|
$7,265,208 | — | 31 Mar 2024 | |
| Rachael Louise Brake |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
1,400,000
|
$6,958,000 | — | 13 Feb 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.97%
|
171,976
|
$6,748,338 | — | 31 Mar 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
156,013
|
$6,121,950 | — | 31 Mar 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.75%
|
132,584
|
$5,202,596 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.7%
|
124,273
|
$4,876,472 | — | 31 Mar 2024 | |
| Craig Stuart Millian |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
934,645
|
$4,645,186 | — | 13 Feb 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.62%
|
108,808
|
$4,271,058 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.6%
|
106,378
|
$4,174,273 | — | 31 Mar 2024 | |
| Altitude Crest Partners Inc. |
13F
|
Company |
0.59%
|
103,703
|
$4,069,306 | — | 31 Mar 2024 | |
| Prosight Management, LP |
13F
|
Company |
0.57%
|
100,617
|
$3,948,211 | — | 31 Mar 2024 | |
| Eversept Partners, LP |
13F
|
Company |
0.5%
|
88,934
|
$3,489,770 | — | 31 Mar 2024 | |
| Exome Asset Management LLC |
13F
|
Company |
0.5%
|
87,846
|
$3,447,077 | — | 31 Mar 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.38%
|
67,500
|
$2,648,700 | — | 31 Mar 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.36%
|
64,503
|
$2,531,098 | — | 31 Mar 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.36%
|
63,059
|
$2,474,435 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.35%
|
61,554
|
$2,415,379 | — | 31 Mar 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.32%
|
56,941
|
$2,234,365 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.24%
|
43,000
|
$1,687,320 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.23%
|
40,981
|
$1,608,094 | — | 31 Mar 2024 | |
| Atle Fund Management AB |
13F
|
Company |
0.21%
|
38,000
|
$1,491,120 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.2%
|
35,979
|
$1,411,816 | — | 31 Mar 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.2%
|
35,000
|
$1,373,400 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.18%
|
32,400
|
$1,271,376 | — | 31 Mar 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
31,980
|
$1,254,895 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.16%
|
27,995
|
$1,098,524 | — | 31 Mar 2024 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.14%
|
24,880
|
$976,291 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.12%
|
21,200
|
$831,888 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
20,011
|
$785,231 | — | 31 Mar 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
17,946
|
$704,201 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.1%
|
17,673
|
$693,489 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.09%
|
16,075
|
$630,783 | — | 31 Mar 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.09%
|
16,000
|
$627,840 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.09%
|
15,465
|
$606,846 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.09%
|
15,307
|
$600,647 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.09%
|
15,304
|
$600,529 | — | 31 Mar 2024 | |
| Lighthouse Investment Partners, LLC |
13F
|
Company |
0.08%
|
14,943
|
$586,363 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.07%
|
12,314
|
$483,000 | — | 31 Mar 2024 |
Institutional Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) as of Q2 2024
As of 30 Jun 2024,
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) was held by
107 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,752,925 shares.
The largest 10 holders included
Cormorant Asset Management, LP, BlackRock Inc., VANGUARD GROUP INC, Octagon Capital Advisors LP, STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC, Darwin Global Management, Ltd., Ikarian Capital, LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
107
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
81
Q2 2024 holders
107
Holder diff
26
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.